Avita Medical

Avita Medical Limited manufactures the medical device, ReCell, a ‘spray on skin’ device used to treat serious burns. ReCell is CE-approved for use in Europe, with FDA approval anticipated mid 2018 for the USA market.

Curious PR is providing social media content and activation, plus media relations activity, to ensure that news concerning a recent, multi-centre, randomised controlled trial involving ReCell reaches key members of the media, and its significance is understood by medical and consumer audiences, alike. Coverage has been secured in influential titles such as Nursing Times, and national newspaper is expected.